Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

Aldeyra Therapeutics Inc (137.SG)

2.3180
+0.1810
+(8.47%)
At close: 9:49:08 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
60,117.0320
60,117.0320
42,794.0830
62,679.9870
56,219.5360
Operating Income
-60,117.0320
-60,117.0320
-42,794.0830
-62,679.9870
-56,219.5360
Net Non Operating Interest Income Expense
4,265.5880
4,265.5880
5,251.5730
655.3510
-1,556.7380
Pretax Income
-55,851.4440
-55,851.4440
-37,542.5100
-62,024.6360
-57,776.2740
Net Income Common Stockholders
-55,851.4440
-55,851.4440
-37,542.5100
-62,024.6360
-57,776.2740
Diluted NI Available to Com Stockholders
-55,851.4440
-55,851.4440
-37,542.5100
-62,024.6360
-57,776.2740
Basic EPS
-0.94
-0.94
-0.64
-1.06
-1.07
Diluted EPS
-0.94
-0.94
-0.64
-1.06
-1.07
Basic Average Shares
59,484.7940
59,484.7940
58,943.2050
58,405.8970
54,042.1030
Diluted Average Shares
59,484.7940
59,484.7940
58,943.2050
58,405.8970
54,042.1030
Total Operating Income as Reported
-60,117.0320
-60,117.0320
-42,794.0830
-62,679.9870
-56,219.5360
Total Expenses
60,117.0320
60,117.0320
42,794.0830
62,679.9870
56,219.5360
Net Income from Continuing & Discontinued Operation
-55,851.4440
-55,851.4440
-37,542.5100
-62,024.6360
-57,776.2740
Normalized Income
-55,851.4440
-55,851.4440
-37,542.5100
-62,024.6360
-57,776.2740
Interest Income
6,191.8290
6,191.8290
7,323.0080
2,349.4490
185.3630
Interest Expense
1,926.2410
1,926.2410
2,071.4350
1,694.0980
1,742.1010
Net Interest Income
4,265.5880
4,265.5880
5,251.5730
655.3510
-1,556.7380
EBIT
-53,925.2030
-53,925.2030
-35,471.0750
-60,330.5380
-56,034.1730
EBITDA
-53,675.5800
-53,675.5800
-35,208.2950
-60,071.8310
-55,769.9930
Reconciled Depreciation
249.6230
249.6230
262.7800
258.7070
264.1800
Net Income from Continuing Operation Net Minority Interest
-55,851.4440
-55,851.4440
-37,542.5100
-62,024.6360
-57,776.2740
Normalized EBITDA
-53,675.5800
-53,675.5800
-35,208.2950
-60,071.8310
-55,769.9930
12/31/2021 - 9/14/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MSCL.TO Satellos Bioscience Inc.
0.6600
+6.45%
 
RVX.TO Resverlogix Corp.
0.0400
+14.29%
 
IMNN Imunon, Inc.
0.8962
-0.20%
 
PALI Palisade Bio, Inc.
0.7355
+3.97%
 
CRIS Curis, Inc.
1.5800
+5.33%
 
JAGX Jaguar Health, Inc.
8.06
+21.20%
 
DOMH Dominari Holdings Inc.
4.6000
+1.55%
 
ALNY Alnylam Pharmaceuticals, Inc.
242.61
+0.26%
 
VXRT Vaxart, Inc.
0.3600
+4.74%
 
BHVN Biohaven Ltd.
23.40
+9.24%